Table of Contents Author Guidelines Submit a Manuscript
Clinical Study
International Journal of Breast Cancer
Volume 2019, Article ID 4693794, 2 pages
Letter to the Editor

Comment on “Extreme Oncoplastic Surgery for Multifocal/Multicentric and Locally Advanced Breast Cancer”

Division of Breast Surgery, Department of Women’s and Children’s Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli, 8-00168 Rome, Italy

Correspondence should be addressed to Gianluca Franceschini; moc.liamg@07inihcsecnarfaculnaig

Received 31 March 2019; Accepted 4 April 2019; Published 2 June 2019

Academic Editor: Vladimir F. Semiglazov

Copyright © 2019 Gianluca Franceschini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

We read with interest the work of Chaitanyanand Koppiker and colleagues [1] and would like to add some useful suggestions to improve oncological and cosmetic outcomes.

Extreme oncoplastic surgery (EOS) is a breast conserving operation, using oncoplastic techniques, in a patient who requires a mastectomy. It is a promising new concept in the multidisciplinary treatment of selected patients with generally large, greater than 5 cm multifocal or multicentric tumor desiring breast conservation [24].

These oncoplastic techniques allow the resection of a greater amount of breast tissue with safer margins and acceptable aesthetic results increasing breast conservation rates [58].

The indications for EOS are different and various algorithms have been devised to assist with the decision process [35]. Long-term data on recurrence and survival are not available, using this approach. It is expected that the local recurrence will be somewhat higher but that there will be little or no impact on survival [3, 9].

Chaitanyanand Koppiker and colleagues conclude in their study that “Extreme Oncoplastic Surgery followed by RT results in acceptable local-regional control, low rate of complications, and high patient satisfaction. In selected patients, EO could provide a safe alternative for breast conservation surgery instead of mastectomy” [1].

However, a “great surgical hand” in EOS is not enough to optimize the oncological and aesthetic results! We think that a good oncoplastic surgery requires both individual ability and technical skill but also other attributes as dedication, decision-making skills, and the repetitive performance of specific tasks.

So, while performing the extreme oncoplastic breast conserving surgery, the modern oncoplastic surgeon should always follow some specific and crucial steps, such as careful local staging of the disease with ultrasonography, mammography, and magnetic resonance before surgery; adequate radiological preoperative study with localization of tumor and/or calcifications; multidisciplinary discussion, in a dedicated “surgery board”, to choose an oncoplastic technique tailored to patient; intraoperative ultrasound to guide the resection; intraoperative radiological and pathological evaluation of the specimen for definition of lesion and margins of resection; frozen sections should be obtained from a portion of all six faces of the resected specimen; systematic circumferential tumor cavity shaving to have a backup to lumpectomy margins; placement of clips within the excision cavity as a “landmark” to define the tumor bed and guide adjuvant breast radiotherapy; accurate pathological assessment of the specimen using macrosections.

This multidisciplinary path leads more easily to tumor-free margins by keeping the amount of healthy breast tissue excision as low as possible; while performing oncoplastic procedures, it would be useful to bear in mind these recommendations and suggestions in order to improve oncological and cosmetic outcomes. The modern breast surgeon must always know where they are going and the repetitive performance of specific tasks could enhance their ability when faced with the extreme and complex oncoplastic procedures.

Conflicts of Interest

All the authors declare no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. The authors declare that they have no conflicts of interest.


  1. C. B. Koppiker, A. U. Noor, S. Dixit et al., “Extreme oncoplastic surgery for multifocal/multicentric and locally advanced breast cancer,” International Journal of Breast Cancer, vol. 2019, Article ID 4262589, 8 pages, 2019. View at Publisher · View at Google Scholar
  2. Clinical Practice Guidelines in Oncology (NCCN). Breast Cancer (NCCN Guidelines) Version 2019 – March, 2019.
  3. M. J. Silverstein, N. Savalia, S. Khan, and J. Ryan, “Extreme oncoplasty: breast conservation for patients who need mastectomy,” The Breast Journal, vol. 21, no. 1, pp. 52–59, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Silverstein, “Radical mastectomy to radical conservation (extreme oncoplasty): a revolutionary change,” Journal of the American College of Surgeons, vol. 222, no. 1, pp. 1–9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. W. P. Weber, S. D. Soysal, M. El-Tamer et al., “First international consensus conference on standardization of oncoplastic breast conserving surgery,” Breast Cancer Research and Treatment, vol. 165, no. 1, pp. 139–149, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Franceschini, D. Terribile, S. Magno et al., “Update on oncoplastic breast surgery,” European Review for Medical and Pharmacological Sciences, vol. 16, no. 11, pp. 1530–1540, 2012. View at Google Scholar · View at Scopus
  7. G. Franceschini, S. Magno, C. Fabbri et al., “Conservative and radical oncoplastic approches in the surgical treatment of breast cancer,” European Review for Medical and Pharmacological Sciences, vol. 12, no. 6, pp. 387–396, 2008. View at Google Scholar · View at Scopus
  8. M. C. Strach, T. Prasanna, Y. M. Kirova et al., “Optimise not compromise: the importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery,” Critical Review in Oncology/Hematology, vol. 134, pp. 10–21, 2019. View at Publisher · View at Google Scholar
  9. A. Crown, R. Laskin, F. G. Rocha, and J. Grumley, “Extreme oncoplasty: expanding indications for breast conservation,” The American Journal of Surgery, pii: S0002-9610(18)31453-3, 2019. View at Publisher · View at Google Scholar